Removal and Degradation of Pharmaceutically Active Compounds in Wastewater Treatment

Sara Rodriguez-Mozaz holds a PhD in Applied Chemistry (2005) and has been a Research Scientist at the Catalan Institute for Water Research (ICRA) in Spain since 2009. Her research focuses on the origin, fate and ecological impact of various emerging contaminants (pharmaceuticals, endocrine disruptors and other urban derived contaminants) in the aquatic environment, including biota. She is also studying the removal and transformation of these emerging compounds by means of alternative water treatments principally designed for water reuse. She has published over 100 peer-reviewed papers and has been involved in several national and international projects, including ECsafeSEAFOOD and StARE. She is currently participating in the H2020 projects SCOREwater and HYDROUSA and in the national project PLAS-MED. Paqui Blánquez Cano (PhD) is an Associate Professor at the Chemical, Biological and Environmental Engineering Department, Universitat Autònoma de Barcelona (UAB). A Chemical Engineer who completed her PhD in 2005, she is currently the assistant director of teaching action at the Engineering School (UAB). She conducts her research as part of the “Biodegradation of Industrial Contaminants and Waste Valorisation” Group, whose goal is to develop processes for the biodegradation of industrial pollutants in effluents as well as in soils. She has published 35 papers in indexed journals and participated in 14 competitive projects.Montserrat Sarrà is an Associate Professor at the Engineering School, Universitat Autònoma de Barcelona (UAB), where she also completed her PhD in Biotechnology (1994). She is a former coordinator of the PhD Program in Environmental Science and Technology (UAB) (2006-2018) and the current coordinator of the Degree Program in Chemical Engineering. Her research interests focus on the bioremediation of xenobiotic compounds and the development of corresponding treatment processes. She conducts her research at the Department of Chemical, Biological and Environmental Engineering. She has participated in 16 competitive projects and published more than 60 papers in international journals.

• Environmental risk assessment of pharmaceuticals in wastewater treatment.- Fate and removal of pharmaceuticals in CAS for water and sewage sludge reuse.- New Insights into the Occurrence of Micropollutants and the Management and Treatment of Hospital Effluent.- Suspect and Non-target Screening Methodologies for the Evaluation of the Behaviour of Polar Organic Micropollutants and Changes in the Molecule Fingerprint During Water Treatment.- Perspectives on the feasibility of using enzymes for pharmaceutical removal in wastewater.- Fungal reactors: a solution for the removal of pharmaceuticals in urban and hospital wastewater.- Novel Constructed Wetland Configurations for the Removal of Pharmaceuticals in Wastewater.- Microalgae-Based Processes for the Removal of Pharmaceuticals in Wastewater.- Removal of Pharmaceuticals from Wastewater by Membrane Bioreactors: Factors, Mechanisms, and Perspectives.- Adsorptive Removal of Pharmaceutically Active Compounds from Wastewater.- Removal of Pharmaceutically Active Compounds (PhACs) in Wastewater by Ozone and Advanced Oxidation Processes.- Removal and Degradation of Pharmaceutically Active Compounds (PhACs) in Wastewaters by Solar Advanced Oxidation Processes.- Advanced Electrochemical Processes for the Elimination of Pharmaceutical Compounds in Contaminated Waters.- Sonochemical advanced oxidation processes for the removal of pharmaceuticals in wastewater effluents.- Correction to: Advanced Electrochemical Processes for the Elimination of Pharmaceutical Compounds in Contaminated Waters.